Additionally, upregulated lncRNA LINC00618 binds to lymphoid-specific helicase (LSH) protein, leading to reduced SLC7A11 expression and GSH levels, heightened lipid ROS, and enhanced ferroptosis, thereby presenting a potential therapeutic target for AML treatment [192]. The gene discussed is HELLS; the disease is acute myeloid leukemia.